This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
It incorporates age, body mass index (BMI), and atrial fibrillation to aid in the diagnosis of HFpEF. The newly developed HFpEF-ABA score model estimates the probability of HFpEF in individual patients based on three simple clinical variables: age, BMI, and atrial fibrillation.
Notably, MAG showed superior survival for patients with a BMI less than 40, whereas patients with a BMI of 40 or higher had superior survival with SAG. The only patients where single arterial grafting resulted in better survival were severely obese,” said Dr. Sabik.
BackgroundIndividuals diagnosed with type 2 diabetes mellitus (T2DM) commonly exhibit elevated lipid levels and an increased body mass index (BMI). The impact of BMI on the efficacy of statins in reducing lipid levels among diabetic patients remains uncertain.
Researchers examined STS registry data on ~109k patients ages 40 to 75 years who received isolated bioprosthetic (94k) or mechanical (15k) AVR over 11 years and found that mechanical valve use decreased by about half (from 20% in 2008 to below 10% in 2019). They also often had lower BMI (31.0 vs 71.8%) or prior PCI (6.7 vs 23.6%).
Therefore, this study aims to elucidate the association between CVD and the severity of COPD.MethodsIn this cross-sectional study involving 7,152 individuals with COPD.,
BMI variability has been associated with increased cardiovascular disease risk in individuals with type 2 diabetes, however comparison between clinical studies and real-world observational evidence has been la.
The triglyceride glucose (TyG) index, TyG-body mass index (TyG-BMI), and triglyceride-density lipoprotein cholesterol ratio (TG/HDL-C) are substitute indicators for insulin resistance (IR). This study aimed to.
Patients with low-to-normal body mass index (BMI; < 25.0 kg/m2) were underrepresented in major randomized controlled trials on sodium-glucose cotransporter 2 (SGLT2) inhibitors for type 2 diabetes. The present st.
Incidence of stroke and ischemic heart disease are declining around the world, except for in a handful of regions, according to research in PLOS Global Public Health.
The TyG-BMI index, which is a reliable indicator of insulin resistance (IR), has been found to have a significant correlation with the occurrence of cardiovascular events. However, there still lacks study on t.
Clinical information, parameters from left ventricular myocardial work and traditional two - dimensional strain echocardiography were collected and analyzed.ResultsAfter LSG, significant reductions in body mass index (BMI), diastolic blood pressure (DBP) and weight were observed.
BMI) to receive Roux-en-Y gastric bypass and medical therapy or only receive medical therapy, finding that after five years… Far more gastric bypass patients cut their BP medication use by at least 30% (80.7% The GATEWAY trial assigned 100 participants (76% women, 43.8 of them achieved BPs below 130/80 mm Hg (vs.
The interaction between body mass index (BMI) and NT-proBNP with respect to heart failure (HF) risk remains incompletely defined. Hospitalization for heart failure (HHF) was examined across strata of baseline BMI and NT-proBNP. pg/mL lower NT-proBNP per 1 kg/m 2 higher BMI; p<0.001). vs. 0.6%, 1.3% vs. 4.0%, and 8.1%
Understanding the relationship between serum ferritin levels and cardiovascular outcomes in type 2 diabetes is crucial for improving risk stratification and guiding therapeutic interventions aimed at preventin.
Excess weight, as measured by BMI, is typically considered a measure of excess body fat. And the research suggests that it is this excess visceral fat (VAT) that is driving most of the risk. When someone is classified as being of ‘normal’ weight, that typically means they have a BMI of less than 25.
Major Trends in Global CVD and Risks The 2023 Almanac presents crucial insights into the Global Burden of Disease (GBD) for the period 1990-2022, revealing five major trends in global cardiovascular diseases (CVD) and associated risks, each with profound implications for clinical practice and research. in High-Income Asia Pacific to 432.3
In addition, abelacimab consistently reduced bleeding risk in patients 75 years of age and older regardless of renal function, body mass index (BMI), and the use of concomitant antiplatelet therapy. The ARR in patients 75 years of age and older was 6.2% compared to 4.2% in patients less than 75 years. in the low-risk category to 7.1%
The researchers examined carotid plaque specimens from 257 patients with asymptomatic carotid artery disease, analyzing their plaque for the presence of 11 MNPs, and tracking the patients’ cardiovascular outcomes over 34 months. age, BMI, comorbidities, prior events), the presence of MNPs in plaque came with a 4.5-times
Researchers measured body composition, blood metabolites (including glucose and ketones), and glycemic control using advanced tools like bioelectrical impedance analysis (for body fat and lean mass) and continuous glucose monitoring (CGM). kg/m² reduction in BMI, and decreased their body fat percentage by 1.9%.
Researchers find that in East and West Sub-Saharan Africa, East and Central Asia and Oceania, ischemic heart disease is increasing, which may be attributed to eight factors that include diet, high BMI, household air pollution and more.
This study aimed to investigate the outcomes of ATAAD surgery across various body mass index (BMI) categories, focusing on the implications of the upper hemisternotomy (UHS) approach. Based on BMI (WS/T 428-2013), patients were categorized into normal weight, overweight, and obese. for predicting postoperative hypoxemia, with 76.3%
Data were collected from the MPH AF Ablation Registry with the approval of the institutional research board. Results Our patient cohort was older, with higher BMI, greater CHA2DS2-VASc scores, and larger left atrial sizes compared to similar previously published cohorts, while gender balance and other characteristics were similar.
Although some studies have examined the association between the triglyceride glucose-body mass index (TyG-BMI) and cardiovascular outcomes in the cardio-renal-metabolic (CRM) background, none have explored its.
Triglyceride-glucose-BMI (TyG-BMI) index is a surrogate marker of insulin resistance and an important predictor of cardiovascular disease. However, the predictive value of TyG-BMI index in the progression of n.
Among participants with baseline body mass index (BMI) above 30 kg/m2, 70.4% Research shows that a 10 point reduction in systolic blood pressure helps lower the risk of coronary heart disease (17%), stroke (27%), heart failure (28%), and all-cause mortality (13%). reduced their weight within 3 months with a mean reduction of 8.8
In a recent study published in Circulation: Heart Failure , researchers analyzed a large group of individuals with various cardiopulmonary diseases who had undergone right heart catheterization. This research sheds light on the nuanced dynamics between obesity, right ventricular function, and cardiovascular health outcomes.
Associations between metabolic status and metabolic changes with the risk of cardiovascular outcomes have been reported. However, the role of genetic susceptibility underlying these associations remains unexpl.
The triglyceride glucose-body mass index (TyG-BMI) is recognized as a reliable surrogate for evaluating insulin resistance and an effective predictor of cardiovascular disease. However, the link between TyG-BM.
1 Researchers used DNA samples from a total of 144 Japanese men between 65 and 72 years of age to calculate biological age acceleration using several well-established biological clocks: the Horvath clock, the Hannum clock, the PhenoAge clock, the GrimAge clock, and the FitAge clock. A recent study provides us with some novel insight.
Triglyceride glucose (TyG) index and triglyceride glucose-body mass index (TyG-BMI) are recognised as convenient p. Insulin resistance (IR) significantly contributes to cardiovascular disease (CVD) development.
Triglyceride glucose-body mass (TyG-BMI) index, sedentary behavior (SB) and physical activity (PA) are independently associated with all-cause mortality and myocardial infarction (MI). However, it remains uncl.
Insulin resistance is linked to an increased risk of frailty, yet the comprehensive relationship between the triglyceride glucose-body mass index (TyG-BMI), which reflects weight, and frailty, remains unclear.
The current classification systems relies on anthropometric measurements, such as BMI. Obesity is a complex, diverse and multifactorial disease that has become a major public health concern in the last decades.
The triglyceride glucose-body mass index (TyG-BMI) has been established as a convenient and reliable marker for assessing insulin resistance (IR) and has been shown to be significantly correlated with stroke.
Association between body mass index (BMI) and clinical outcomes in PARADISE-MI. ( A ) Histogram for BMI (kg/m 2 ), ( B ) adverse events for BMI subgroups, and spline model curves for ( C ) the primary composite outcome and ( D ) cardiovascular (CV) death by BMI subgroups. 100 patient-years for BMI 40kg/m 2 ).
The results were consistent with much of the epidemiological evidence we have on the research question, showing a statistically significant increase in the risk of T2DM with higher red meat intake among all three cohorts. Model 3 is nearly identical to model 2, but omits the adjustment for BMI. to 1.12, 1.24 to 1.10, and 1.46
Current literature is deficient in robust evidence delineating the correlation between the triglyceride glucose-body mass index (TyG-BMI) and the incidence of stroke. Consequently, this investigation seeks to.
This study is designed to investigate the impact of body mass index (BMI) on the short-term outcomes of patients undergoing off-pump coronary artery bypass graft (OPCAB) surgery.
Individuals who are overweight or obese often develop insulin resistance, mediation of the association between body mass index (BMI) and stroke risk through the triglyceride-glucose index (TyG) seems plausible.
2, 3] This association is more pronounced for those with class I obesity, which is a body mass index (BMI) between 30-35 kg/m2. These individuals tend to have a better prognosis when compared to both individuals with normal weight (BMI of 18.5 to 25 kg/m2) and underweight (BMI less than 18.5
Previous research has demonstrated that adults with obesity who were given once-weekly survodutide 4.8 Knop, MD, PhD, professor of endocrinology and director of the Center for Clinical Metabolic Research at Gentofte Hospital, University of Copenhagen in Denmark, and consultant endocrinologist at Steno Diabetes Center in Copenhagen.
BMI, body mass index; eGFR, estimated glomerular filtration rate; NYHA, New York Heart Association. Discontinuation and reinitiation of mineralocorticoid receptor antagonists (MRA) in patients with heart failure and reduced ejection fraction (HFrEF).
BMI, body mass index; CI, confidence interval; LVEF, left ventricular ejection fraction; NT-proBNP, N-terminal pro-B-type natriuretic peptide. In addition, dapagliflozin was safe and well-tolerated, irrespective of COPD status.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content